From knowledge-based potentials to combinatorial lead design in silico.
Computational methods are becoming increasingly used in the drug discovery process. In this Account, we review a novel computational method for lead discovery. This method, called CombiSMoG for "combinatorial small molecule growth", is based on two components: a fast and accurate knowledge-based scoring function used to predict binding affinities of protein-ligand complexes, and a Monte Carlo combinatorial growth algorithm that generates large numbers of low-free-energy ligands in the binding site of a protein. We illustrate the advantages of the method by describing its application in the design of picomolar inhibitors for human carbonic anhydrase.